19 results on '"Aguiar MG"'
Search Results
2. THU0505 Low literacy but not parental smoking or breast feeding worsens outcome in juvenile idiopathic arthritis in a low income population
- Author
-
Rocha, FAC, primary, Vasques, JI, additional, Rocha, LN, additional, Aguiar, MG, additional, Accioly, JPE, additional, Lechiu, CN, additional, Costa, LHA, additional, Silva, MFCD, additional, Feitosa, ARX, additional, Rocha, HAL, additional, and Rabelo, CN, additional
- Published
- 2017
- Full Text
- View/download PDF
3. Combination of the Topical Photodynamic Therapy of Chloroaluminum Phthalocyanine Liposomes with Fexinidazole Oral Self-Emulsifying System as a New Strategy for Cutaneous Leishmaniasis Treatment.
- Author
-
Silva RA, Damasio DS, Coelho LD, de Morais-Teixeira E, Queiroz-Junior CM, Souza PE, Azevedo RB, Tedesco A, Ferreira LA, Oliveira MC, and Aguiar MG
- Abstract
Cutaneous leishmaniasis (CL) is a neglected tropical disease. The treatment is restricted to drugs, such as meglumine antimoniate and amphotericin B, that exhibit toxic effects, high cost, long-term treatment, and limited efficacy. The development of new alternative therapies, including the identification of effective drugs for the topical and oral treatment of CL, is of great interest. In this sense, a combination of topical photodynamic therapy (PDT) with chloroaluminum phthalocyanine liposomes (Lip-ClAlPc) and the oral administration of a self-emulsifying drug delivery system containing fexinidazole (SEDDS-FEX) emerges as a new strategy. The aim of the present study was to prepare, characterize, and evaluate the efficacy of combined therapy with Lip-ClAlPc and SEDDS-FEX in the experimental treatment of Leishmania (Leishmania) major . Lip-ClAlPc and SEDDS-FEX were prepared, and the antileishmanial efficacy study was conducted with the following groups: 1. Lip-ClAlPc (0.05 mL); 2. SEDDS-FEX (50 mg/kg/day); 3. Lip-ClAlPc (0.05 mL)+SEDDS-FEX (50 mg/kg/day) combination; 4. FEX suspension (50 mg/kg/day); and 5. control (untreated). BALB/c mice received 10 sessions of topical Lip-ClAlPc on alternate days and 20 consecutive days of SEDDS-FEX or FEX oral suspension. Therapeutical efficacy was evaluated via the parasite burden (limiting-dilution assay), lesion size (mm), healing of the lesion, and histological analyses. Lip-ClAlPc and SEDDS-FEX presented physicochemical characteristics that are compatible with the administration routes used in the treatments. Lip-ClAlPc+SEDDS-FEX led to a significant reduction in the parasitic burden in the lesion and spleen when compared to the control group ( p < 0.05) and the complete healing of the lesion in 43% of animals. The Lip-ClAlPc+SEDDS-FEX combination may be promising for the treatment of CL caused by L. major.
- Published
- 2024
- Full Text
- View/download PDF
4. A new oral self-emulsifying drug delivery system improves the antileishmania efficacy of fexinidazole in vivo.
- Author
-
Damasio DSDN, Antunes PA, Lages EB, Morais-Teixeira E, Vital KD, Cardoso VN, Fernandes SOA, Aguiar MG, and Ferreira LAM
- Subjects
- Animals, Emulsions, Drug Delivery Systems, Administration, Oral, Solubility, Emulsifying Agents, Nitroimidazoles, Antiprotozoal Agents pharmacology
- Abstract
The aim of this study was to develop, characterize and evaluate the in vivo oral efficacy of self-emulsifying drug delivery systems (SEDDS) containing fexinidazole (FEX) in the experimental treatment of visceral leishmaniasis (VL). The developed FEX-SEDDS formulation presented as a clear, yellowish liquid, with absence of precipitate. The droplet size, polydispersion index and zeta potential after dilution in water (1:200) was of 91 ± 3 nm, 0.242 ± 0.005 and -16.7 ± 0.2, respectively. In the simulated gastric and intestinal media, the FEX-SEDDS had a size of 97 ± 1 and 106 ± 9 nm, respectively. The FEX retention in droplet after SEDDS dilution in simulated gastrointestinal media was almost 100 %. Antileishmanial efficacy studies showed that FEX-SEDDS was the only treatment able to significantly (p < 0.05) reduce the parasite burden in the liver and spleen of animals experimentally infected with Leishmania infantum. Our intestinal permeability data suggest that FEX-SEDDS showed no evidence of injury to the intestinal mucosa. These findings suggest that FEX-SEDDS can be a promising oral alternative for the treatment of VL caused by L. infantum., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
5. SARS-CoV-2 in children with cancer in Brazil: Results of a multicenter national registry.
- Author
-
Corso MCM, Soares VJ, Amorim AMP, Cipolotti R, Magalhães IMQ, Lins MM, Forsait S, Silva LN, de Sousa AVL, Alves NG, do Prado SI, Silva KAS, Carbone EK, Brumatti M, Santiago P, Pereira KMMO, Carlesse FAMC, Aguiar MG, Marques RF, Rechenmacher C, Daudt LE, and Michalowski MB
- Subjects
- Adolescent, Body Mass Index, Brazil epidemiology, COVID-19 epidemiology, Child, Child, Preschool, Female, Humans, Male, Neoplasms epidemiology, Registries, Retrospective Studies, Risk Factors, SARS-CoV-2 isolation & purification, Survival Analysis, COVID-19 complications, Neoplasms complications
- Abstract
Background: Strategies to mitigate the impact of COVID-19 in special populations are complex and challenging. Few studies have addressed the impact of COVID-19 on pediatric patients with cancer in low- and middle-income countries., Methods: Multicenter observational cohort study with prospective records and retrospective analyses starting in April 2020 in 21 pediatric oncology centers distributed throughout Brazil., Participants: Patients under 18 years of age who are infected by the SARS-CoV-2 virus (confirmed diagnosis through reverse transcriptase-polymerase chain reaction [RT-PCR]) while under treatment at pediatric oncology centers. The variables of interest included clinical symptoms, diagnostic and therapeutic measures. The repercussions of SARS-CoV-2 infection on cancer treatment and general prognosis were monitored., Results: One hundred seventy-nine patients were included (median age 6 [4-13] years, 58% male). Of these, 55.9% had acute leukemia and 34.1% had solid tumors. The presence of SARS-CoV-2 was diagnosed by RT-PCR. Various laboratory markers were analyzed, but showed no correlation with outcome. Children with low or high BMI for age had lower overall survival (71.4% and 82.6%, respectively) than those with age-appropriate BMI (92.7%) (p = .007). The severity of presentation at diagnosis was significantly associated with outcome (p < .001). Overall mortality in the presence of infection was 12.3% (n = 22)., Conclusion: In children with cancer and COVID-19, lower BMI was associated with worse prognosis. The mortality in this group of patients (12.3%) was significantly higher than that described in the pediatric population overall (∼1%)., (© 2021 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
6. Efficacy of nanoemulsion with Pterodon emarginatus Vogel oleoresin for topical treatment of cutaneous leishmaniasis.
- Author
-
Kawakami MYM, Zamora LO, Araújo RS, Fernandes CP, Ricotta TQN, de Oliveira LG, Queiroz-Junior CM, Fernandes AP, da Conceição EC, Ferreira LAM, Barros ALB, Aguiar MG, and Oliveira AEMFM
- Subjects
- Administration, Topical, Animals, Cytokines metabolism, Disease Models, Animal, Drug Compounding, Drug Therapy, Combination, Emulsions, Female, Host-Parasite Interactions, Leishmania mexicana growth & development, Leishmaniasis, Cutaneous parasitology, Leishmaniasis, Cutaneous pathology, Meglumine Antimoniate pharmacology, Mesocricetus, Mice, Inbred BALB C, Nanoparticles, Parasite Load, Plant Extracts isolation & purification, Skin parasitology, Skin pathology, Trypanocidal Agents isolation & purification, Mice, Fabaceae chemistry, Leishmania mexicana drug effects, Leishmaniasis, Cutaneous drug therapy, Plant Extracts pharmacology, Skin drug effects, Trypanocidal Agents pharmacology
- Abstract
Cutaneous leishmaniasis (CL) is a neglected tropical skin disease caused by the protozoan genus Leishmania. The treatment is restricted to a handful number of drugs that exhibit toxic effects, limited efficacy, and drug resistance. Additionally, developing an effective topical treatment is still an enormous unmet medical challenge. Natural oils, e.g. the oleoresin from P. emarginatus fruits (SO), contain various bioactive molecules, especially terpenoid compounds such as diterpenes and sesquiterpenes. However, its use in topical formulations can be impaired due to the natural barrier of the skin for low water solubility compounds. Nanoemulsions (NE) are drug delivery systems able to increase penetration of lipophilic compounds throughout the skin, improving their topical effect. In this context, we propose the use of SO-containing NE (SO-NE) for CL treatment. The SO-NE was produced by a low energy method and presented suitable physicochemical characteristic: average diameter and polydispersity index lower than 180 nm and 0.2, respectively. Leishmania (Leishmania) amazonensis-infected BALB/c mice were given topical doses of SO or SO-NE. The topical use of a combination of SO-NE and intraperitoneal meglumine antimoniate reduced lesion size by 41 % and tissue regeneration was proven by histopathological analyses. In addition, a reduction in the parasitic load and decreased in the level of IFN-γ in the lesion may be associated, as well as a lower level of the cytokine IL-10 may be associated with a less intense inflammatory process. The present study suggests that SO-NE in combination meglumine antimoniate represents a promising alternative for the topical treatment of CL caused by L. (L.) amazonensis., (Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
7. Safety profile of meglumine antimoniate intralesional infiltration for cutaneous leishmaniasis.
- Author
-
Fernandes HJ, da Silva RE, Ramalho DB, Aguiar MG, Silveira JN, and Cota G
- Subjects
- Adult, Antiprotozoal Agents adverse effects, Drug Hypersensitivity etiology, Female, Humans, Injections, Intralesional, Male, Meglumine Antimoniate adverse effects, Middle Aged, Risk, Antiprotozoal Agents administration & dosage, Leishmaniasis, Cutaneous drug therapy, Meglumine Antimoniate administration & dosage
- Abstract
Objectives : Cutaneous leishmaniasis is a neglected disease, associated with high morbidity, which is partially due to the toxicity of available therapies. The pentavalent antimonial derivatives intralesional infiltration has proven to be as effective as the intravenous drug-based therapy, however, there is a lack of robust safety data. Methods : Phase II, uncontrolled, unicenter clinical trial to assess the safety profile of a standardized meglumine antimionate intralesional therapy, based on weekly infiltrations. Results : Fifty-three patients were studied, predominantly men (60%) and young adults (43.7 ± 17.1 years). Overall, 86.9% of the patients had at least one clinical adverse event. Local events were the most frequent (83%), followed by systemic ones (47.3%). Fourteen participants (26%) presented biochemical abnormalities. In all cases, laboratorial alterations were classified as mild and treatment discontinuation was not required. Differently, the two hypersensitivity (3.8%) reactions observed led to permanent treatment interruption. QTc interval prolongation was recorded in 14 patients (25.5%). The following risk associations to adverse events were identified in the multiple analysis: hypertension with systemic clinical events and smoking with QT interval prolongation. Expert commentary : In general, MA-IL was well tolerated and although associated with local and systemic adverse events, there was a low risk of high intensity or severe complications.
- Published
- 2020
- Full Text
- View/download PDF
8. Topical photodynamic therapy with chloroaluminum phthalocyanine liposomes is as effective as systemic pentavalent antimony in the treatment of experimental cutaneous leishmaniasis.
- Author
-
Lopes SC, Silva RA, Novais MV, Coelho LD, Ferreira LA, Souza PE, Tedesco A, Azevedo RB, Aguiar MG, and Oliveira MC
- Subjects
- Administration, Topical, Animals, Liposomes, Mesocricetus, Mice, Inbred BALB C, Spleen parasitology, Antimony administration & dosage, Indoles administration & dosage, Leishmaniasis, Cutaneous drug therapy, Organometallic Compounds administration & dosage, Photochemotherapy methods, Photosensitizing Agents administration & dosage
- Abstract
Background: In the Americas, one of the main causative species of cutaneous leishmaniasis is Leishmania (Leishmania) amazonensis. The systemic antimonials remain the most largely used option for disease control. However, this drug has significant toxicity. The development of new alternative therapies, including the identification of effective drugs for topical treatment of cutaneous leishmaniasis, is of utmost interest. In this sense, photodynamic therapy emerges as a new strategy. The aim of this study was to develop the chloroaluminum phthalocyanine-loaded liposome, characterize it, and evaluate its stability and efficacy in the topical treatment of cutaneous leishmaniasis caused by L. (L.) amazonensis., Methods: Liposomes composed of egg phosphatidylcholine were prepared by Bangham's method. Storage stability of phthalocyanine-loaded liposomes was evaluated at 30 and 60 days after preparation. For the in vivo evaluation, the animals were infected with L. (L.) amazonensis and divided into groups: chloroaluminium phthalocyanine-loaded liposome, blank liposome, meglumine antimoniate (200 mgSb
+5 /Kg/day), and control. The lesion size was determined weekly after the beginning of the treatment. Upon completion, parasites were recovered from the skin lesion and spleen and evaluated by limiting dilution assay., Results: Chloroaluminum phthalocyanine-loaded liposomes were stable and showed adequate characteristics for topical administration. The topical chloroaluminum phthalocyanine-loaded liposome was as effective as systemic pentavalent antimony in reducing the parasitic load in the lesion and spleen in infected animals., Conclusions: The present study showed that photodynamic therapy with chloroaluminum phthalocyanine-loaded liposomes is a promising strategy for the treatment of American cutaneous leishmaniasis caused by L. (L.) amazonensis., (Copyright © 2019 Elsevier B.V. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
9. Evaluation of disease activity in a low-income juvenile idiopathic arthritis cohort.
- Author
-
Rocha FAC, Landim JIVD, Aguiar MG, Accioly JPE, Lechiu CN, Costa LHA, Júnior CNR, da Rocha LN, and Rocha HAL
- Subjects
- Abatacept therapeutic use, Adalimumab therapeutic use, Adolescent, Arthritis, Juvenile drug therapy, Brazil, Child, Cohort Studies, Etanercept therapeutic use, Female, Humans, Male, Methotrexate therapeutic use, Poverty, Prognosis, Severity of Illness Index, Young Adult, Antirheumatic Agents therapeutic use, Arthritis, Juvenile diagnosis
- Abstract
Determine disease activity in a low income juvenile idiopathic arthritis (JIA) cohort. 164 JIA patients from families with less than US$ 4500.00/capita mean annual income followed in Fortaleza-CE, Brazil, were cross-sectionally evaluated between May 2015-April 2016. Mean age was 14 ± 5.1 years (95 female) with 10.31 ± 3.7 years disease duration. Polyarticular category predominated, with 63 (38.4%) patients, followed by 40 (24%) enthesitis-related (ERA), and 36 (22%) oligoarticular. All but 1 out of 84 parents declared less than US$ 10,000.00 annual family income. Eighty-eight (60.7%) were receiving methotrexate and 19 (13%) leflunomide including 12 (63%) using both; 46 (28%) were on biologic DMARD including 20 (43.5%) adalimumab, 17 (41.5) etanercept, 5 (10.8%) tocilizumab, 2 (4.2%) abatacept, and 1 (2.1%) each on infliximab and canakinumab. Mean CHAQ and JADAS27 were 0.36 ± 0.55 and 5.31 ± 8.5, respectively. Thirty-two (20%) out of 159 patients had deformities. A bivariate analysis revealed that polyarticular had more deformities than oligoarticular patients (p = 0.002; OR = 2.389; 95% CI 1.37-4.14). Logistic regression showed no association between high JADAS and family income (p = 0.339; OR = 1.45; 95% CI 0.67-3.31). A general linear model showed significantly lower CHAQ score in patients from families earning more as compared to those earning less than 300.00 US$ monthly (p = 0.002). This study reports JIA disease activity in a low income population. Low income apparently did not influence prognosis given the low mean JADAS27 and CHAQ scores vis-à-vis data from other cohorts.
- Published
- 2019
- Full Text
- View/download PDF
10. Plasma antimony determination during cutaneous leishmaniasis treatment with intralesional infiltration of meglumine antimoniate.
- Author
-
de Aguiar MG, Gonçalves JE, Souza MD, de Silva RE, Silveira JN, and Cota G
- Subjects
- Adult, Female, Humans, Injections, Intralesional, Leishmaniasis, Cutaneous pathology, Male, Middle Aged, Young Adult, Antimony blood, Antiprotozoal Agents administration & dosage, Leishmaniasis, Cutaneous drug therapy, Meglumine Antimoniate administration & dosage
- Abstract
Objectives: To evaluate the antimony (Sb) in plasma of patients who underwent a standardised meglumine antimoniate (MA) intralesional infiltration protocol for cutaneous leishmaniasis treatment., Methods: The level of Sb in plasma was determined by atomic absorption spectroscopy, before and 1, 2, 4 and 6 hours after the first intralesional infiltration of MA to determine the parameters peak concentrations (C
1 h ), area under curve of drug concentration in plasma from zero to 6 h (AUC0-6 h ) and elimination half-life (t½) of Sb. Blood samples were also collected weekly during the treatment period, always before infiltration., Results: Fourteen patients underwent MA intralesional infiltration with doses ranging from 0.8 to 9 mg Sb/kg at the first infiltration. The C1 h ranged from 3850 to 47 095 mg × h/L and was the highest concentration obtained for 11 of 14 patients after the first intralesional infiltration of MA. A rapid initial phase of distribution lasting up to 4 h (2.6 ± 0.34 h) was followed by a slower elimination phase. Total skin lesion area, C1 h and AUC(0-6 h) were related to the dose of Sb infiltered (P < 0.05). Plasma Sb in samples collected weekly before the infiltration revealed antimony concentrations below the quantification limit (15.0 μg Sb/l) during the treatment period., Conclusions: Sb is quickly absorbed and eliminated after intralesional administration of MA, in a pattern similar to that reported with the Sb systemic administration. Using a therapeutic schedule limited to weekly intralesional infiltration of doses <10 mg Sb/kg does not result in plasma Sb accumulation., (© 2018 John Wiley & Sons Ltd.)- Published
- 2018
- Full Text
- View/download PDF
11. Experiences in the therapeutic itineraries of mothers of children with intellectual disabilities.
- Author
-
Cerqueira MM, Alves RO, and Aguiar MG
- Subjects
- Adult, Child, Child Health Services, Health Services Accessibility, Health Services for Persons with Disabilities, Humans, Middle Aged, Young Adult, Adaptation, Psychological, Intellectual Disability therapy, Mothers psychology
- Abstract
The scope of this study is to describe the experiences of mothers of children with intellectual disabilities who have been treated in a specialized institution in Feira de Santana, State of Bahia, during their therapeutic itineraries. The study adopted a qualitative approach and was conducted by means of semi-structured interviews. The results revealed that the discovery that their child has an intellectual disability is accepted by their mothers with emotions of shock, denial, anger, negotiation, depression and subsequent acceptance. The difficulties in therapeutic itineraries begin after the moment the child is diagnosed as having an intellectual disability, due to the lack of experience of health professionals in communicating the fact, which leads the mothers to search for other health services. Despite access to healthcare being one of the principles of the Unified Health System (SUS), therapeutic itineraries are fraught with difficulties at a geographical, economic and functional level. Intellectual disability is a health issue demanding constant care, and its impacts have repercussions in the family dynamics, identities and roles, requiring comprehensive attention to the children and their caretakers, especially in the type of support such that they may maintain their protective roles.
- Published
- 2016
- Full Text
- View/download PDF
12. Postmortem Diagnosis of Dengue as an Epidemiological Surveillance Tool.
- Author
-
Cavalcanti LP, Braga DN, da Silva LM, Aguiar MG, Castiglioni M, Silva-Junior JU, Araújo FM, Pereira RA, Malta DL, and Pompeu MM
- Subjects
- Antibodies, Viral, Brazil epidemiology, Cause of Death, Dengue mortality, Forensic Medicine, Humans, Pathology, Clinical, Specimen Handling, Dengue diagnosis, Dengue epidemiology, Population Surveillance methods
- Abstract
Dengue remains a problem in Brazil, and a substantial number of cases that progress to death are not diagnosed by health services. We evaluated the impact of a protocol adopted by the Coroner's Office Rocha Furtado (CO-RF) for the detection of unreported deaths from dengue in Brazil. We evaluated prospectively cases of deaths referred to the CO-RF with suspicion of dengue and those referred with other diagnosis in which the pathologists suspected dengue as the cause of death. Biological material was collected from all bodies autopsied, for which the suspected cause of death was dengue, between January 2011 and December 2012. Of the 214 bodies autopsied, 134 (62.6%) tested positive for dengue; of these cases, 121 were classified as dengue according to the World Health Organization's case definition (1997 or 2009, as appropriate). Thus, CO-RF detected 90 deaths from dengue, which were not suspected during disease progression. This CO-RF protocol, through a combined effort of the surveillance and laboratory teams, increased the detection of fatal dengue cases by 5-fold. This is the largest series of autopsies performed in cases of death related to dengue in the world to date., (© The American Society of Tropical Medicine and Hygiene.)
- Published
- 2016
- Full Text
- View/download PDF
13. Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by Leishmania (Viannia) braziliensis.
- Author
-
de Morais-Teixeira E, Aguiar MG, Soares de Souza Lima B, Ferreira LA, and Rabello A
- Subjects
- Administration, Oral, Administration, Topical, Animals, Appointments and Schedules, Disease Models, Animal, Drug Therapy, Combination methods, Injections, Intramuscular, Leishmania braziliensis isolation & purification, Leishmaniasis, Cutaneous parasitology, Male, Meglumine Antimoniate, Mesocricetus, Phosphorylcholine administration & dosage, Skin parasitology, Spleen parasitology, Treatment Outcome, Antiprotozoal Agents administration & dosage, Leishmania braziliensis drug effects, Leishmaniasis, Cutaneous drug therapy, Meglumine administration & dosage, Organometallic Compounds administration & dosage, Paromomycin administration & dosage, Phosphorylcholine analogs & derivatives
- Abstract
Objectives: This study aimed to evaluate the efficacy of binary combinations of suboptimal schedules of drugs with different administration routes (topical paromomycin, intramuscular meglumine antimoniate and oral miltefosine) to treat animals infected with Leishmania (Viannia) braziliensis., Methods: Hamsters were inoculated with L. (V.) braziliensis and after ulceration of lesions, divided into seven groups: untreated control, paromomycin, miltefosine, meglumine antimoniate, meglumine antimoniate + paromomycin, miltefosine + paromomycin and meglumine antimoniate + miltefosine. Meglumine antimoniate and miltefosine were administered at low doses and topical paromomycin at a single daily application regimen. The animals were treated for 20 consecutive days (meglumine antimoniate and/or paromomycin) and/or 10 alternate days (miltefosine). Lesion sizes were determined weekly. Upon completion of treatment, parasites were recovered from skin lesions and spleens and evaluated by limiting dilution assay., Results: The combinations of a once daily application of paromomycin with low doses of miltefosine or meglumine antimoniate yielded higher efficacies in reducing the parasite load as well as lesion size when compared with any of these drugs administered as monotherapy regimens at the same suboptimal schedules., Conclusions: Considering the parameters evaluated, the combinations of a systemic therapy with topical treatment were more effective than monotherapy with each of these drugs. These combinations may represent an alternative combination strategy for the treatment of leishmaniasis caused by L. (V.) braziliensis., (© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2015
- Full Text
- View/download PDF
14. Evaluation of the World Health Organization 2009 classification of dengue severity in autopsied individuals, during the epidemics of 2011 and 2012 in Brazil.
- Author
-
Cavalcanti LP, Braga DN, Pompeu MM, Lima AA, Silva LM, Aguiar MG, Castiglioni M, Araújo FM, Malta DL, and Queiroz A
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Autopsy, Brazil epidemiology, Child, Child, Preschool, Dengue epidemiology, Epidemics, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Retrospective Studies, Severe Dengue epidemiology, Symptom Assessment standards, Young Adult, Dengue classification, Severity of Illness Index, World Health Organization
- Abstract
Introduction: The dengue classification proposed by the World Health Organization (WHO) in 2009 is considered more sensitive than the classification proposed by the WHO in 1997. However, no study has assessed the ability of the WHO 2009 classification to identify dengue deaths among autopsied individuals suspected of having dengue. In the present study, we evaluated the ability of the WHO 2009 classification to identify dengue deaths among autopsied individuals suspected of having dengue in Northeast Brazil, where the disease is endemic., Methods: This retrospective study included 121 autopsied individuals suspected of having dengue in Northeast Brazil during the epidemics of 2011 and 2012. All the autopsied individuals included in this study were confirmed to have dengue based on the findings of laboratory examinations., Results: The median age of the autopsied individuals was 34 years (range, 1 month to 93 years), and 54.5% of the individuals were males. According to the WHO 1997 classification, 9.1% (11/121) of the cases were classified as dengue hemorrhagic fever (DHF) and 3.3% (4/121) as dengue shock syndrome. The remaining 87.6% (106/121) of the cases were classified as dengue with complications. According to the 2009 classification, 100% (121/121) of the cases were classified as severe dengue. The absence of plasma leakage (58.5%) and platelet counts <100,000/mm3 (47.2%) were the most frequent reasons for the inability to classify cases as DHF., Conclusions: The WHO 2009 classification is more sensitive than the WHO 1997 classification for identifying dengue deaths among autopsied individuals suspected of having dengue.
- Published
- 2015
- Full Text
- View/download PDF
15. Drug delivery systems for the topical treatment of cutaneous leishmaniasis.
- Author
-
Carneiro G, Aguiar MG, Fernandes AP, and Ferreira LA
- Subjects
- Administration, Cutaneous, Aminoquinolines administration & dosage, Amphotericin B administration & dosage, Animals, Humans, Imiquimod, Naphthoquinones administration & dosage, Paromomycin administration & dosage, Phosphorylcholine administration & dosage, Phosphorylcholine analogs & derivatives, Skin Absorption, Antiprotozoal Agents administration & dosage, Drug Delivery Systems, Leishmaniasis, Cutaneous drug therapy
- Abstract
Introduction: The parenteral administration of pentavalent antimonials for the treatment of all forms of leishmaniasis, including cutaneous leishamniasis (CL), has several limitations. Therapy is long, requiring repeated doses and the adverse reactions are frequent. Topical treatment is an attractive alternative for CL, offering significant advantages over systemic therapy: fewer adverse effects, ease of administration, and lower costs., Areas Covered: This review covers, from 1984 to the present, the progress achieved for the development of topical treatment for CL, using different drugs such as paromomycin (PA), imiquimod, amphotericin B (AmB), miltefosine, and buparvaquone. PA is the most commonly studied drug, followed by AmB and Imiquimod. These drugs were incorporated in conventional dosage forms or loaded in lipid nanocarries, which have been used mainly for improved skin delivery and antileishmanial activity., Expert Opinion: Developing an effective topical treatment for CL using these antileishmanial drugs still remains a great challenge. Insights into the most promising delivery strategies to improve treatment of CL with PA and AmB using conventional dosage forms, lipid nanocarriers, and combined therapy are presented and discussed. The results obtained with combined therapy and alternative delivery systems are promising perspectives for improving topical treatment of CL.
- Published
- 2012
- Full Text
- View/download PDF
16. Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis.
- Author
-
Aguiar MG, Pereira AM, Fernandes AP, and Ferreira LA
- Subjects
- Administration, Oral, Administration, Topical, Animals, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents pharmacology, Antiprotozoal Agents administration & dosage, Antiprotozoal Agents pharmacology, Female, Leishmaniasis parasitology, Mice, Mice, Inbred BALB C, Paromomycin administration & dosage, Paromomycin pharmacology, Phosphorylcholine administration & dosage, Phosphorylcholine pharmacology, Phosphorylcholine therapeutic use, Anti-Bacterial Agents therapeutic use, Antiprotozoal Agents therapeutic use, Leishmania drug effects, Leishmaniasis drug therapy, Paromomycin therapeutic use, Phosphorylcholine analogs & derivatives, Skin physiopathology
- Abstract
This study aimed to investigate the activity of a combination of topical paromomycin gel and oral miltefosine for the treatment of experimental cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis. The efficacy of the combination, evaluated by measuring lesion size and parasite burden in the skin and spleen, was assessed in BALB/c mice infected by L. (L.) amazonensis. The miltefosine was administered orally at 10 mg/kg of body weight/day for 10 days, while 10% paromomycin gel was applied topically twice a day for 20 days. Treatment of the experimentally infected animals with a topical paromomycin-oral miltefosine combination induced a statistically significant reduction in lesion size and parasite burden in the skin and spleen, with complete healing of ulcers, compared with those treated with a placebo group. A combination of topical paromomycin gel and oral miltefosine provided enhanced efficacy in the treatment of L. (L.) amazonensis-infected mice, showing activity higher than that observed for the monotherapeutic regimens.
- Published
- 2010
- Full Text
- View/download PDF
17. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
- Author
-
Aguiar MG, Silva DL, Nunan FA, Nunan EA, Fernandes AP, and Ferreira LA
- Subjects
- Administration, Oral, Administration, Topical, Animals, Disease Models, Animal, Drug Therapy, Combination, Female, Leishmaniasis, Cutaneous parasitology, Leishmaniasis, Cutaneous pathology, Mice, Mice, Inbred BALB C, Phosphorylcholine administration & dosage, Phosphorylcholine therapeutic use, Skin parasitology, Skin pathology, Spleen parasitology, Treatment Outcome, Leishmania major drug effects, Leishmaniasis, Cutaneous drug therapy, Paromomycin administration & dosage, Paromomycin therapeutic use, Phosphorylcholine analogs & derivatives
- Abstract
Objectives: This study aimed to investigate the activity of the combination of topical paromomycin gel and oral miltefosine for the treatment of experimental cutaneous leishmaniasis caused by Leishmania (Leishmania) major., Methods: The efficacy of the combination, evaluated by measuring lesion size and parasite burden in the skin and spleen, was assessed in BALB/c mice infected by L. (L.) major. Miltefosine was administered orally at 25 mg/kg/day for 10 days, while 10% paromomycin gel was applied topically twice a day for 10 days., Results: Treatment of the experimentally infected animals with topical paromomycin + oral miltefosine combination induced a statistically significant reduction in lesion size and parasite burden in the skin, with complete healing of ulcers, as compared with those treated with oral miltefosine or placebo. Furthermore, topical paromomycin + oral miltefosine combination was as effective as topical paromomycin alone to reduce the lesion size and parasite load in lesions. However, the efficacy of the combination was significantly higher than that observed for the other treatments, including topical paromomycin alone, in reducing the parasite burden in spleen., Conclusions: The combination of topical paromomycin gel and oral miltefosine provides an enhanced efficacy in the treatment of L. (L.) major-infected mice, thus presenting a significantly higher activity than that observed for the monotherapeutic regimens.
- Published
- 2009
- Full Text
- View/download PDF
18. [Family health program: a space for the reconstruction of social representations of the health-disease process?].
- Author
-
Gomes LO and Aguiar MG
- Subjects
- Humans, Sociology, Family Health, Health Promotion
- Abstract
A qualitative study that investigated the social representations of health-disease process of families accompanied by Family Health Program (FHP) in the rural zone in the municipal of Lafaiete Coutinho, Bahia, Brazil, aiming at analyzing the social representations of families about the health-disease process. Data were colected through a semi-structured interview with 23 members of several families. Content analysis was used do understand sense nucleous. The results showed that the FHP interferes in the reconstruction of social representations of health-disease process, through the organization of health services and of social production of health. It was concluded the FHP has contributed for the democratization of knowbdge of health-disease process, however it is necessary to dimystify cultural values reinforced by a model of attention that emphasized the recovery of diseases.
- Published
- 2006
- Full Text
- View/download PDF
19. [Reflections on qualitative research methods in nursing].
- Author
-
Rezende MA, Ribeiro MR, and Aguiar MG
- Subjects
- Philosophy, Nursing, Sensitivity and Specificity, Nursing Methodology Research methods
- Abstract
This essay brings considerations about quantitative and qualitative research methods in Nursing. It boards the quantitative and qualitative methods specifications, makes the distinction between method and technique, and gives emphasis to the episthemological pressuppositions which gives basis to the method.
- Published
- 1992
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.